NASDAQ:ZEAL
Delisted
Zealand Pharma Stock News
$17.59
+0 (+0%)
At Close: Jan 27, 2023
Zealand Pharma launches long-term incentive program for Zealand's Executive Management and employees for 2021
07:00am, Wednesday, 12'th May 2021
Company announcement – No. 28 / 20 2 1
Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10 am ET) to Present First Quarter Results for 2021
04:00am, Wednesday, 05'th May 2021
C ompany a nnouncement – No. 27 / 202 1
Company announcement – No. 26 / 20 2 1
Zealand Pharma's Annual General Meeting 2021
10:00am, Thursday, 15'th Apr 2021
Company announcement – No. 22 / 2021
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
08:00am, Tuesday, 13'th Apr 2021
Company announcement – No. 21/ 2021
With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?
12:23pm, Monday, 12'th Apr 2021
A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next.
Company announcement – No. 20/ 2021
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
08:00am, Friday, 09'th Apr 2021
Company announcement – No. 19/ 2021
Zealand Pharma to participate in upcoming investor conferences
04:05pm, Thursday, 25'th Mar 2021
Company announcement – No. 17 / 2020
Company announcement – No. 16 / 2021
Company announcement – No. 15 / 2021
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
09:52am, Saturday, 20'th Mar 2021
Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the bigges
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
11:20am, Friday, 19'th Mar 2021
Company announcement – No. 14 / 2021
Zealand Pharma convenes its Annual General Meeting 2021
12:42pm, Tuesday, 16'th Mar 2021
Company Announcement – No. 13 / 2021
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q4 2020 Results - Earnings Call Transcript
04:45pm, Thursday, 11'th Mar 2021
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q4 2020 Results - Earnings Call Transcript
